Jul 30, 2013 by Dan Carroll3 Potential Solutions for Pfizer's Generic Drug BusinessWith the announcement of Pfizer's re-organization, what's ahead for the company's low-growth generics division?
Jul 30, 2013 by Dan CarrollPfizer's Healthy Quarter Can't Stop the Dow's SlideMerck heads lower after currency issues whack the company's earnings.
Jul 29, 2013 by Dan CarrollPfizer's Generic Split Buffers the Dow's Falling FinancialsBank of America leads the index lower on a red day in the markets.
Jul 27, 2013 by Dan CarrollSequenom's 30% Nosedive Leads an Up-and-Down Week in BiotechArray BioPharma wins big in phase 2 trial results, but that's barely enough to lift the sector as a whole.
Jul 27, 2013 by Dan CarrollBetter Dividend: Pfizer vs. Bristol-Myers SquibbTwo of Big Pharma's largest firms square off to determine which stock offers the best payout
Jul 27, 2013 by Dan Carroll3 Winners and Losers Halfway Through Earnings SeasonWith a few weeks of earnings to go, we review three of the biggest movers in health care so far.
Jul 27, 2013 by Dan CarrollThe S&P 500's 3 Worst Health-Care Stocks of 2013While markets have been on a tear, these three stocks have slumped.
Jul 26, 2013 by Dan CarrollToyota's Slowing Sales Lead the Nikkei's PullbackCanon takes a dive this week despite Japanese prices posting a welcome increase.
Jul 26, 2013 by Dan CarrollThe S&P 500's 3 Best Health-Care Stocks of 2013Three big winners from biotech and medical devices lead the S&P's health stocks higher this year.
Jul 26, 2013 by Dan CarrollThe Trends Investors Need to Watch in China's SlowdownWith Beijing reluctant to take an active hand in its slowing economy, investing in strong companies is more important than ever for China investors
Jul 26, 2013 by Dan CarrollDanger Looms at BASF and Siemens as Germany's DAX FallsGermany's PMI ticks up, but many are doubtful that Europe's largest economy can save the faltering eurozone.
Jul 26, 2013 by Dan CarrollFalling Finance Stocks Drag the Dow to a Negative Finish for the WeekThe Dow's few risers can't keep the index in the green as American Express and JPMorgan fall.
Jul 25, 2013 by Dan CarrollBetter Dividend: AstraZeneca vs. Bristol-Myers SquibbBoth stocks offer strong dividend yields, but is either worth your money?
Jul 25, 2013 by Dan CarrollCaterpillar's Slog Brings the Dow Down to EarthThe blue-chip index hasn't made much of a mark today as Caterpillar and Home Depot lead the laggards lower.
Jul 24, 2013 by Dan CarrollAT&T and Caterpillar's Earnings Whiffs Pull Down the DowAlcoa also falls after Caterpillar's stock takes a dive.
Jul 23, 2013 by Dan CarrollUnited Technologies' Earnings Hit Keeps the Dow Flying HigherAerospace parts sales help UTC boost its full-year outlook as shares soar.
Jul 23, 2013 by Dan CarrollBetter Dividend: Johnson & Johnson vs. Abbott LabsThese dividends go head-to-head with the two most prominent diversified health care companies.
Jul 22, 2013 by Dan CarrollMcDonald's Earnings Miss Weighs on the DowDisney and Intel rank among the leading losers on a flat day in the markets.
Jul 20, 2013 by Dan CarrollAmgen's Acquisition Ambition Leads Biotechs' RiseThe sector posted a good, if not spectacular, week behind Amgen's gains and Idenix's bounce back from year-to-date losses.
Jul 19, 2013 by Dan CarrollJapan's Election Looms Large for the Nikkei's FutureA big win by Shinzo Abe's LDP could mean even bigger rewards for investors.
